Targeting of the Eukaryotic Translation Initiation Factor 4A Against Breast Cancer Stemness
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting of the Eukaryotic Translation Initiation Factor 4A Against Breast Cancer Stemness
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-12-06
DOI
10.3389/fonc.2019.01311
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The CXCR4-LASP1-eIF4F Axis Promotes Translation of Oncogenic Proteins in Triple-Negative Breast Cancer Cells
- (2019) Cory M. Howard et al. Frontiers in Oncology
- Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance
- (2019) Sangita Sridharan et al. Frontiers in Oncology
- Translation initiation factors and their relevance in cancer
- (2018) Columba de la Parra et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Eukaryotic initiation factor 4F — sidestepping resistance mechanisms arising from expression heterogeneity
- (2018) Jennifer Chu et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- OCT4 but not SOX2 expression correlates with worse prognosis in surgical patients with triple-negative breast cancer
- (2018) Jia-Ming Zhang et al. Breast Cancer
- Toward a Kinetic Understanding of Eukaryotic Translation
- (2018) Masaaki Sokabe et al. Cold Spring Harbor Perspectives in Biology
- Translational Control in Cancer
- (2018) Nathaniel Robichaud et al. Cold Spring Harbor Perspectives in Biology
- Principles of Translational Control
- (2018) John W.B. Hershey et al. Cold Spring Harbor Perspectives in Biology
- SOX2 Promotes Cell Proliferation and Metastasis in Triple Negative Breast Cancer
- (2018) Peng Liu et al. Frontiers in Pharmacology
- Targeting Cancer Stemness in the Clinic: From Hype to Hope
- (2018) Caner Saygin et al. Cell Stem Cell
- Targeting Cancer Stem Cell Redox Metabolism to Enhance Therapy Responses
- (2018) Ming Luo et al. SEMINARS IN RADIATION ONCOLOGY
- OCT4, SOX2, and NAN OG positive expression correlates with poor differentiation, advanced disease stages, and worse overall survival in HER2+ breast cancer patients
- (2018) Fan Yang et al. OncoTargets and Therapy
- High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer
- (2018) Gloria V. Echeverria et al. Nature Communications
- Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models
- (2018) Xia Liu et al. Cancer Discovery
- Sensitization of renal carcinoma cells to TRAIL-induced apoptosis by rocaglamide and analogs
- (2018) Ancy D. Nalli et al. Scientific Reports
- Stem cell-like breast cancer cells with acquired resistance to metformin are sensitive to inhibitors of NADH-dependent CtBP dimerization
- (2018) Arindam Banerjee et al. CARCINOGENESIS
- Translational Dysregulation in Cancer: Molecular Insights and Potential Clinical Applications in Biomarker Development
- (2017) Christos Vaklavas et al. Frontiers in Oncology
- ALDH+/CD44+ cells in breast cancer are associated with worse prognosis and poor clinical outcome
- (2016) Yan Qiu et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Translational dysregulation in cancer: eIF4A isoforms and sequence determinants of eIF4A dependence
- (2015) F. Raza et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Targeting the eIF4A RNA helicase as an anti-neoplastic approach
- (2015) Jennifer Chu et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Targeting the eIF4F Translation Initiation Complex: A Critical Nexus for Cancer Development
- (2015) J. Pelletier et al. CANCER RESEARCH
- Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer
- (2015) Michael D. Brooks et al. Cell Stem Cell
- Subclonal diversification of primary breast cancer revealed by multiregion sequencing
- (2015) Lucy R Yates et al. NATURE MEDICINE
- Targeting the translation machinery in cancer
- (2015) Mamatha Bhat et al. NATURE REVIEWS DRUG DISCOVERY
- The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape
- (2015) A Modelska et al. Cell Death & Disease
- Metabolic plasticity of cancer stem cells
- (2015) Ming Luo et al. Oncotarget
- Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells
- (2015) Rachana Trivedi et al. Frontiers in Oncology
- 4EGI-1 targets breast cancer stem cells by selective inhibition of translation that persists in CSC maintenance, proliferation and metastasis
- (2015) Tingfang Yi et al. Oncotarget
- Critical role of retinoid/rexinoid signaling in mediating transformation and therapeutic response of NUP98-RARG leukemia
- (2014) J J Qiu et al. LEUKEMIA
- Rocaglamide overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells by attenuating the inhibition of caspase-8 through cellular FLICE-like-inhibitory protein downregulation
- (2014) ZHOU LUAN et al. Molecular Medicine Reports
- RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer
- (2014) Andrew L. Wolfe et al. NATURE
- eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies
- (2014) Lise Boussemart et al. NATURE
- Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
- (2014) Suling Liu et al. Stem Cell Reports
- Breast cancer stem cells and epithelial mesenchymal plasticity – Implications for chemoresistance
- (2013) Cletus A. Pinto et al. CANCER LETTERS
- Heterogeneity of Neoplastic Stem Cells: Theoretical, Functional, and Clinical Implications
- (2013) P. Valent et al. CANCER RESEARCH
- Retinoic Acid Signaling Is Essential for Embryonic Hematopoietic Stem Cell Development
- (2013) Bhaskar Chanda et al. CELL
- Targeting cancer stem cells: emerging role of Nanog transcription factor
- (2013) Cheng-Wen (Ken) Wu et al. OncoTargets and Therapy
- Breast cancer, side population cells and ABCG2 expression
- (2012) K.M. Britton et al. CANCER LETTERS
- A Detailed Mammosphere Assay Protocol for the Quantification of Breast Stem Cell Activity
- (2012) Frances L. Shaw et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Association between SDF1-3′A or CXCR4 gene polymorphisms with predisposition to and clinicopathological characteristics of prostate cancer with or without metastases
- (2012) Ferruh K. İşman et al. MOLECULAR BIOLOGY REPORTS
- The clonal and mutational evolution spectrum of primary triple-negative breast cancers
- (2012) Sohrab P. Shah et al. NATURE
- eIF4F suppression in breast cancer affects maintenance and progression
- (2012) Z Nasr et al. ONCOGENE
- The Paradox of Triple Negative Breast Cancer: Novel Approaches to Treatment
- (2011) Monica Fornier et al. Breast Journal
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Eukaryotic initiation factor 4F: a vulnerability of tumor cells
- (2011) Teresa Lee et al. Future Medicinal Chemistry
- Rocaglamide and a XIAP inhibitor cooperatively sensitize TRAIL-mediated apoptosis in Hodgkin's lymphomas
- (2011) Marco Giaisi et al. INTERNATIONAL JOURNAL OF CANCER
- Coexpression of Oct4 and Nanog Enhances Malignancy in Lung Adenocarcinoma by Inducing Cancer Stem Cell-Like Properties and Epithelial-Mesenchymal Transdifferentiation
- (2010) S.-H. Chiou et al. CANCER RESEARCH
- TGF- Promotion of Gli2-Induced Expression of Parathyroid Hormone-Related Protein, an Important Osteolytic Factor in Bone Metastasis, Is Independent of Canonical Hedgehog Signaling
- (2010) R. W. Johnson et al. CANCER RESEARCH
- Rocaglamide breaks TRAIL resistance in HTLV-1-associated adult T-cell leukemia/lymphoma by translational suppression of c-FLIP expression
- (2010) M Bleumink et al. CELL DEATH AND DIFFERENTIATION
- Genes that mediate breast cancer metastasis to the brain
- (2009) Paula D. Bos et al. NATURE
- The Molecular Mechanism Governing the Oncogenic Potential of SOX2 in Breast Cancer
- (2008) Yupeng Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model
- (2008) Marie-Eve Bordeleau et al. JOURNAL OF CLINICAL INVESTIGATION
- Taxanes, microtubules and chemoresistant breast cancer
- (2007) Barbara T. McGrogan et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now